BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 5, 2015
View Archived Issues
Sato and Pola Pharma to comarket topical agent for tinea unguium
Read More
Nivolumab in esophageal cancer
Read More
First-in-class PFKFB4 inhibitor suppresses tumor growth in mice
Read More
Serum microRNAs revealed as potential biomarkers for diabetes
Read More
Glucokinase regulatory protein may be associated with PCOS
Read More
Pfizer acquires Nimenrix and Mencevax from GlaxoSmithKline
Read More
FDA accepts Jazz Pharmaceuticals' NDA for defibrotide in hepatic veno-occlusive disease
Read More
Progentec and OMRF enter collaboration to develop autoimmune diagnostic tests
Read More
Generex to acquire controlling share of Hema Diagnostic Systems
Read More
Karolinska Development divests holding in XSpray Microparticles
Read More
Kura initiates new phase II trial of tipifarnib in peripheral T-cell lymphoma
Read More
PD/PK of topoisomerase inhibitor ACT-387042
Read More
Mitsubishi Tanabe licenses rights to Regeneron's fasinumab
Read More
Combination of repurposed antidepressants induces autophagy in glioma cells
Read More
Otsuka files NDA in Japan for carteolol/latanoprost for glaucoma
Read More
FDA awards orphan drug designation to RGX-111 for MPS I
Read More
Beijing Hanmi divulges ROR-gamma receptor antagonists
Read More
Boehringer Ingelheim discloses SYK inhibitors
Read More
NIH awards two grants to OptiKira
Read More
Roche and Genentech patent Pim kinase inhibitors
Read More
Pfizer introduces DGAT-2 inhibitors
Read More
Hinova reports deuterated PARP inhibitors
Read More
Allergan adds to esthetics assets with Kythera acquisition
Read More
FDA accepts Sandoz BLA for biosimilar etanercept
Read More
Biotron releases interim data from phase II study of BIT-225 in HCV
Read More
New company Neon Therapeutics to develop neoantigen-based cancer immunotherapies
Read More
EMA accepts Ultragenyx's MAA for aceneuramic acid prolonged release
Read More
Kaken files application for approval of periodontal regenerative agent KCB-1D
Read More
FDA approves Keytruda and companion diagnostic for PD-L1-expressing NSCLC tumors
Read More